Switching to rosuvastatin plus ezetimibe in statin-treated stroke patients with low-density lipoprotein cholesterol levels above 70 mg/dL (SWITCH): a prospective observational study
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q2
- 저널
- LIPIDS IN HEALTH AND DISEASE24(1) · #359 · 2025
- 피인용
- Web of Science 0Scopus 0
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2024 4.2
- ISSN
- 1476-511X
저자
- Yang, Wookjin제1저자Asan Med Ctr, Dept Neurol, Seoul, South Korea
- Lee, Yeong-BaeGachon Univ, Coll Med, Gil Med Ctr, Dept Neurol, Incheon, South Korea
- Kim, Eung-GyuInje Univ, Busan Paik Hosp, Coll Med, Dept Neurol, Busan, South Korea
- 조한진Pusan Natl Univ, Sch Med, Pusan Natl Univ Hosp, Dept Neurol, Busan, South Korea
- Yu, SungwookKorea Univ, Anam Hosp, Coll Med, Dept Neurol, Seoul, South Korea
- Kim, Joon-TaeChonnam Natl Univ, Chonnam Natl Univ Hosp, Med Sch, Dept Neurol, Gwangju, South Korea
- Shin, Jong WookChungnam Natl Univ, Chungnam Natl Univ Hosp, Coll Med, Dept Neurol, Daejeon, South Korea
- Lee, Soo JooEulji Univ, Daejeon Eulji Med Ctr, Sch Med, Dept Neurol, Daejeon, South Korea
- Kim, Beom JoonSeoul Natl Univ, Bundang Hosp, Coll Med, Dept Neurol, Seongnam, South Korea
- Hong, Ji ManAjou Univ, Med Ctr, Sch Med, Dept Neurol, Suwon, South Korea
- Koh, Seong-HoHanyang Univ, Guri Hosp, Coll Med, Dept Neurol, Guri, South Korea
- An, Sang JoonCatholic Kwandong Univ, Int St Marys Hosp, Coll Med, Dept Neurol, Incheon, South Korea
- Cho, A-HyunCatholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Neurol, Seoul, South Korea
- Jung, Jin-ManKorea Univ, Coll Med, Ansan Hosp, Dept Neurol, Ansan, South Korea
- Cho, Hyun-JiCatholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Neurol, Incheon, South Korea
- Kim, ChulhoHallym Univ, Chuncheon Sacred Heart Hosp, Coll Med, Dept Neurol, Chunchon, South Korea
- Lee, Eung-JoonSeoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurol, 101 Daehak Ro, Seoul 03080, South Korea
- Kim, Jeong-MinSeoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurol, 101 Daehak Ro, Seoul 03080, South Korea
- Lee, Seung-Hoon교신저자Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurol, 101 Daehak Ro, Seoul 03080, South Korea
초록
Background Effective lipid management is critical for secondary stroke prevention, however, many patients fail to achieve target low-density lipoprotein cholesterol (LDL-C) levels with statin monotherapy. This study evaluated the real-world effectiveness and safety of switching from statin monotherapy to rosuvastatin plus ezetimibe combination therapy (REZ) in patients with stroke. Methods This multicenter, prospective, observational study enrolled patients with stroke and baseline LDL-C >= 70 mg/dL despite statin monotherapy from 16 Korean stroke centers. Participants were switched to REZ at doses of 5/10 mg, 10/10 mg, or 20/10 mg at the investigators'discretion. Lipid profiles were assessed at three and six months. The primary outcome was achieving LDL-C < 70 mg/dL at six months. Results In total, 1,431 participants enrolled between May 2021 and March 2023 were eligible (mean age 65.3 +/- 10.6 years; 66.8% male). Among 994 participants completing follow-up, the mean baseline LDL-C was 98.9 +/- 22.4 mg/dL. At six months, 708 (71.2%) achieved LDL-C < 70 mg/dL. Mean LDL-C decreased to 62.7 +/- 22.1 mg/dL at three months and to 62.0 +/- 22.0 mg/dL at six months. The effectiveness of REZ remained consistent across different REZ dosages and regardless of changes in statin intensity during the switch. REZ was particularly effective in patients with diabetes (odds ratio [95% confidence interval], 1.85 [1.32-2.59]; P < 0.001) and baseline LDL-C 70-99 mg/dL (2.71 [2.04-3.59]; P < 0.001). Fewer participants achieved stricter targets (LDL-C < 55 mg/dL or LDL-C < 70 mg/dL plus 50% reduction). Conclusions Switching to REZ effectively reduced LDL-C in patients with stroke receiving statin monotherapy with LDL-C >= 70 mg/dL, offering potential benefits for secondary cardiovascular prevention in real-world practice.
키워드
EzetimibeHydroxymethylglutaryl-CoA reductase inhibitorsLow-density lipoprotein cholesterolStrokeCARDIOVASCULAR EVENTSTHERAPYRISKMETAANALYSISEFFICACYSAFETYTARGET
식별자
- Scopus EID
- 2-s2.0-105021509995
- WoS UID
- 001615498700001



로그인
연구물 목록으로